Ausdal Financial Partners »

Vertex Pharmaceuticals Incorporated shares owned by Ausdal Financial Partners

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Ausdal Financial Partners from 13F filings

Historical chart of Ausdal Financial Partners investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Ausdal Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Ausdal Financial Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $245k 587 418.01
2023-12-31 $201k 493 406.89
2021-12-31 $3.3M 15k 219.61
2015-12-31 $4.0k 31 129.03

More positions owned by Ausdal Financial Partners

Ishares Tr Short Treas Bd (SHV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Caterpillar (CAT)
Ishares Tr Msci Acwi Etf (ACWI)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Rus Md Cp Gr Etf (IWP)
Apple (AAPL)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Microsoft Corporation (MSFT)
Wisdomtree Tr Floatng Rat Trea (USFR)
Ishares Tr Rus 1000 Etf (IWB)

View all positions for Ausdal Financial Partners

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated